These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15716701)

  • 21. The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study.
    Rizos E; Bairaktari E; Kostoula A; Hasiotis G; Achimastos A; Ganotakis E; Elisaf M; Mikhailidis DP
    J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):127-34. PubMed ID: 12808486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage.
    Coats A; Jain S
    J Hum Hypertens; 2017 Jun; 31(6):376-381. PubMed ID: 28252041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nebivolol and metoprolol: long-term effects on inflammation and oxidative stress in essential hypertension.
    Serg M; Kampus P; Kals J; Zagura M; Zilmer M; Zilmer K; Kullisaar T; Eha J
    Scand J Clin Lab Invest; 2012 Sep; 72(5):427-32. PubMed ID: 22708640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension.
    Georgescu A; Popov D; Dragan E; Dragomir E; Badila E
    Eur J Pharmacol; 2007 Sep; 570(1-3):149-58. PubMed ID: 17612521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats.
    Toblli J; Cao G; Rivas C; Munoz M; Giani J; Dominici F; Angerosa M
    J Hypertens; 2010 May; 28(5):1007-19. PubMed ID: 20411618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric oxide mediated venodilator effects of nebivolol.
    Bowman AJ; Chen CP; Ford GA
    Br J Clin Pharmacol; 1994 Sep; 38(3):199-204. PubMed ID: 7826820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nebivolol: an endothelium-friendly selective β1-adrenoceptor blocker.
    Gao Y; Vanhoutte PM
    J Cardiovasc Pharmacol; 2012 Jan; 59(1):16-21. PubMed ID: 21283024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nebivolol: a multifaceted antioxidant and cardioprotectant in hypertensive heart disease.
    Khan MU; Zhao W; Zhao T; Al Darazi F; Ahokas RA; Sun Y; Bhattacharya SK; Gerling IC; Weber KT
    J Cardiovasc Pharmacol; 2013 Nov; 62(5):445-51. PubMed ID: 23921314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients.
    Poirier L; Cléroux J; Nadeau A; Lacourcière Y
    J Hypertens; 2001 Aug; 19(8):1429-35. PubMed ID: 11518851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of nebivolol and atenolol on small arteries and microcirculatory endothelium-dependent dilation in hypertensive patients undergoing isometric stress.
    Arosio E; De Marchi S; Prior M; Zannoni M; Lechi A
    J Hypertens; 2002 Sep; 20(9):1793-7. PubMed ID: 12195121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of a two-week treatment with nebivolol and nifedipine in hypertensive patients suffering from COPD.
    Cazzola M; Matera MG; Ruggeri P; Sanduzzi A; Spicuzza L; Vatrella A; Girbino G
    Respiration; 2004; 71(2):159-64. PubMed ID: 15031571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of atenolol and nebivolol in isolated systolic hypertension.
    Dhakam Z; Yasmin ; McEniery CM; Burton T; Brown MJ; Wilkinson IB
    J Hypertens; 2008 Feb; 26(2):351-6. PubMed ID: 18192850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients.
    Celik T; Iyisoy A; Kursaklioglu H; Kardesoglu E; Kilic S; Turhan H; Yilmaz MI; Ozcan O; Yaman H; Isik E; Fici F
    J Hypertens; 2006 Mar; 24(3):591-6. PubMed ID: 16467663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of garlic supplementation on oxidized low density lipoproteins and lipid peroxidation in patients of essential hypertension.
    Dhawan V; Jain S
    Mol Cell Biochem; 2004 Nov; 266(1-2):109-15. PubMed ID: 15646031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nebivolol induces parallel improvement of left ventricular filling pressure and coronary flow reserve in uncomplicated arterial hypertension.
    Galderisi M; D'Errico A; Sidiropulos M; Innelli P; de Divitiis O; de Simone G
    J Hypertens; 2009 Oct; 27(10):2108-15. PubMed ID: 19564794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.
    Tuncer M; Guntekin U; Gunes Y; Gumrukcuoglu HA; Eryonucu B
    Adv Ther; 2008 Jun; 25(6):619-26. PubMed ID: 18563311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of nebivolol on endothelial gene expression during oxidative stress in human umbilical vein endothelial cells.
    Garbin U; Fratta Pasini A; Stranieri C; Manfro S; Mozzini C; Boccioletti V; Pasini A; Cominacini M; Evangelista S; Cominacini L
    Mediators Inflamm; 2008; 2008():367590. PubMed ID: 18437228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial.
    Erdoğan O; Ertem B; Altun A
    Anadolu Kardiyol Derg; 2011 Jun; 11(4):310-3. PubMed ID: 21543293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nebivolol reduces proteinuria and renal NADPH oxidase-generated reactive oxygen species in the transgenic Ren2 rat.
    Whaley-Connell A; Habibi J; Johnson M; Tilmon R; Rehmer N; Rehmer J; Wiedmeyer C; Ferrario CM; Sowers JR
    Am J Nephrol; 2009; 30(4):354-60. PubMed ID: 19609077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence with nebivolol in the treatment of hypertension: a retrospective claims analysis.
    Signorovitch JE; Samuelson TM; Ramakrishnan K; Marynchenko M; Wu EQ; Blum SI; Ramasamy A; Chen S
    Curr Med Res Opin; 2012 Apr; 28(4):591-9. PubMed ID: 22352883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.